Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -16.87% is 74% above its 5-year average of -63.78%, near the high end of its 5-year range (-137.39%–-16.87%).
As of the fiscal period ended Tuesday, June 30, 2026. 55.18% above its 12-month average of -37.64%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -16.87%.
RETURN ON INVESTED CAPITAL (ROIC)
-16.87%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-37.64%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-45.12%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-63.78%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-45.91%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+55.18%
CURRENT VS 3Y AVG
+62.61%
CURRENT VS 5Y AVG
+73.55%
CURRENT VS 10Y AVG
+63.25%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
+52.67%
vs the sector median at left
MacroGenics, Inc.
Market Cap
$231.37M
Return on Invested Capital (ROIC)
-16.87%
TTM Avg
-37.64%
3Y Avg
-45.12%
5Y Avg
-63.78%
Market Cap
$231.77M
Return on Invested Capital (ROIC)
-701.55%
TTM Avg
-3723.51%
3Y Avg
-1911.77%
5Y Avg
-1278.48%
Market Cap
$232.72M
Return on Invested Capital (ROIC)
-25.38%
TTM Avg
-99.58%
3Y Avg
-69.59%
5Y Avg
-61.10%
Market Cap
$227.91M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$235.08M
Return on Invested Capital (ROIC)
6.83%
TTM Avg
8.52%
3Y Avg
10.27%
5Y Avg
10.68%
Market Cap
$227.60M
Return on Invested Capital (ROIC)
-25.73%
TTM Avg
-40.62%
3Y Avg
-54.07%
5Y Avg
-54.31%
Market Cap
$235.66M
Return on Invested Capital (ROIC)
-7.08%
TTM Avg
-12.89%
3Y Avg
-21.42%
5Y Avg
-39.95%
Market Cap
$235.97M
Return on Invested Capital (ROIC)
-6.63%
TTM Avg
16.95%
3Y Avg
21.30%
5Y Avg
28.21%
Market Cap
$236.82M
Return on Invested Capital (ROIC)
-28.14%
TTM Avg
-28.34%
3Y Avg
-154.06%
5Y Avg
-154.06%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MacroGenics, Inc. (MGNX) | $231.37M | -16.87% | -37.64% | -45.12% | -63.78% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $231.77M | -701.55% | -3723.51% | -1911.77% | -1278.48% |
| InflaRx N.V. (IFRX)vs › | $232.72M | -25.38% | -99.58% | -69.59% | -61.10% |
| Vogenx Inc. (VOGX)vs › | $227.91M | N/A | N/A | N/A | N/A |
| Utah Medical Products, Inc. (UTMD)vs › | $235.08M | 6.83% | 8.52% | 10.27% | 10.68% |
| Biodesix, Inc. (BDSX)vs › | $227.60M | -25.73% | -40.62% | -54.07% | -54.31% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $235.66M | -7.08% | -12.89% | -21.42% | -39.95% |
| SIGA Technologies, Inc. (SIGA)vs › | $235.97M | -6.63% | 16.95% | 21.30% | 28.21% |
| BioAge Labs Inc. (BIOA)vs › | $236.82M | -28.14% | -28.34% | -154.06% | -154.06% |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $225.24M | -40.52% | -35.57% | -28.84% | -24.57% |
ROIC
-16.9%
ROE
-34.0%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -16.87% |
| 2026-03-31 | -50.07% |
| 2025-12-31 | -33.28% |
| 2025-09-30 | -50.19% |
| 2025-06-30 | -37.80% |
| 2025-03-31 | -58.80% |
| 2024-12-31 | -53.65% |
| 2024-09-30 | -52.19% |
| 2024-06-30 | -137.39% |
| 2024-03-31 | -95.35% |
| 2023-12-31 | -69.43% |
| 2023-09-30 | -37.03% |
| 2023-06-30 | -36.99% |
| 2023-03-31 | -31.29% |
| 2022-12-31 | -49.43% |
| 2022-09-30 | -131.89% |
| 2022-06-30 | -131.41% |
| 2022-03-31 | -106.75% |
| 2021-12-31 | -77.80% |
| 2021-09-30 | -45.39% |
| 2021-06-30 | -36.48% |
| 2021-03-31 | -35.80% |
| 2020-12-31 | -39.95% |
| 2020-09-30 | -51.67% |
| 2020-06-30 | -60.12% |
| 2020-03-31 | -77.51% |
| 2019-12-31 | -66.28% |
| 2019-09-30 | -61.33% |
| 2019-06-30 | -53.05% |
| 2019-03-31 | -46.47% |
| 2018-12-31 | -62.90% |
| 2018-09-30 | -7.99% |
| 2018-06-30 | -11.00% |
| 2018-03-31 | -12.37% |
| 2017-12-31 | -6.82% |
| 2017-09-30 | -77.26% |
| 2017-06-30 | -60.51% |
| 2017-03-31 | -27.08% |
| 2016-12-31 | -21.03% |
| 2016-09-30 | -16.72% |
| 2016-06-30 | -9.85% |
| 2016-03-31 | -30.96% |
| 2015-12-31 | -5.99% |
| 2015-09-30 | -2.92% |
| 2015-06-30 | 0.39% |
| 2015-03-31 | 3.88% |
| 2014-12-31 | -2094384.85% |
| 2014-09-30 | -1837048.32% |
| 2014-06-30 | -1752535.32% |
| 2013-12-31 | 0.02% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | -22.99% |
